Compile Data Set for Download or QSAR
Report error Found 105 Enz. Inhib. hit(s) with all data for entry = 50008402
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518833(CHEMBL4528993 | US10829446, Compound 45)
Affinity DataIC50: 2nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518832(CHEMBL4455897 | US10829446, Compound 36)
Affinity DataIC50: 8nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518831(CHEMBL4464835 | US10829446, Compound 35)
Affinity DataIC50: 10nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518867(CHEMBL4460509 | US10829446, Compound 157)
Affinity DataIC50: 17nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6B(Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518832(CHEMBL4455897 | US10829446, Compound 36)
Affinity DataIC50: 28nMAssay Description:Inhibition of N-terminal GST-tagged recombinant human KAT6B (431 to end residues) expressed in baculovirus infected Sf9 insect cells using acetyl coe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518845(CHEMBL4473722)
Affinity DataIC50: 43nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase p300(Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50467836(CHEMBL4282264)
Affinity DataIC50: 60nMAssay Description:Inhibition of p300 HAT domain (unknown origin) preincubated for 30 mins followed by histone H4 Peptide (Biotin-C6-GRGKGGKGLGKGGAK) and acetyl coenzym...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518862(CHEMBL4452390)
Affinity DataIC50: 62nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518800(CHEMBL4476153)
Affinity DataIC50: 77nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518791(CHEMBL4520147 | US10829446, Compound 4)
Affinity DataIC50: 120nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518806(CHEMBL4455492)
Affinity DataIC50: 130nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518829(CHEMBL4442753)
Affinity DataIC50: 130nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518828(CHEMBL4538005 | US10829446, Compound 14)
Affinity DataIC50: 160nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518830(CHEMBL4440486)
Affinity DataIC50: 230nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518819(CHEMBL4474291 | US10829446, Compound 33)
Affinity DataIC50: 270nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518858(CHEMBL4562274 | US10829446, Compound 2)
Affinity DataIC50: 290nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518860(CHEMBL4444803)
Affinity DataIC50: 390nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518792(CHEMBL4467566)
Affinity DataIC50: 460nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518801(CHEMBL4470091)
Affinity DataIC50: 490nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518852(CHEMBL4474924)
Affinity DataIC50: 490nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518865(CHEMBL4525503)
Affinity DataIC50: 490nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518803(CHEMBL4455584)
Affinity DataIC50: 520nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518799(CHEMBL4548248)
Affinity DataIC50: 580nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518845(CHEMBL4473722)
Affinity DataIC50: 600nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 15 uM acetyl c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518795(CHEMBL4582659 | US10829446, Compound 29)
Affinity DataIC50: 620nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518872(CHEMBL4473410)
Affinity DataIC50: 740nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518869(CHEMBL4542711)
Affinity DataIC50: 790nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518800(CHEMBL4476153)
Affinity DataIC50: 870nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 15 uM acetyl c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518840(CHEMBL4582784 | US10829446, Compound 1)
Affinity DataIC50: 880nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518807(CHEMBL4579833)
Affinity DataIC50: 910nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518793(CHEMBL4576525)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518862(CHEMBL4452390)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 15 uM acetyl c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518848(CHEMBL4444868)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518812(CHEMBL4568187)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518791(CHEMBL4520147 | US10829446, Compound 4)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 15 uM acetyl c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518836(CHEMBL4568429 | US10829446, Compound 148)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518864(CHEMBL4475760)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518808(CHEMBL4537591)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518802(CHEMBL4441509)
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A(Mouse)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518832(CHEMBL4455897 | US10829446, Compound 36)
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of KAT6A in C57BL/6 mouse embryonic fibroblasts assessed as reduction in cell proliferation after 10 daysMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518806(CHEMBL4455492)
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 15 uM acetyl c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518805(CHEMBL4472625)
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518840(CHEMBL4582784 | US10829446, Compound 1)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 15 uM acetyl c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518856(CHEMBL4466290 | US10829446, Compound 31)
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518857(CHEMBL4462783)
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518859(CHEMBL4453537 | US10829446, Compound 32)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518815(CHEMBL1705311)
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518794(CHEMBL4521188)
Affinity DataIC50: 4.20E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518809(CHEMBL4589336)
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT6A [507-778](Human)
Cancer Therapeutics Crc

Curated by ChEMBL
LigandPNGBDBM50518863(CHEMBL4440821)
Affinity DataIC50: 5.70E+3nMAssay Description:Inhibition of N-terminal NusA-fused His6-tagged human KAT6A (507 to 778 residues) expressed in Escherichia coli BL21 (DE3) cells using 0.4 uM acetyl ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 105 total ) | Next | Last >>
Jump to: